Skip to content

Clinical trials

Phase 2 Endocrine Gland Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine Gland Neoplasms Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20081
20091
20111
20182
20201
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Catalysis SL2
University Health Network, Toronto2
Amgen1
Assistance Publique - Hôpitaux de Paris1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
National Cancer Institute (NCI)1
Thomas Jefferson University1
Xiaoxiang Chen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine Gland Neoplasms10
Endocrine System Diseases5
Neoplasms5
Neoplasms by Site4
Adnexal Diseases3
Carcinoma3
Digestive System Diseases3
Digestive System Neoplasms3
Genital Diseases, Female3
Lymphoma3

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.